Health Care Article: Drug Reimbursement Issues Surrounding the Implementation of Medicare Part D, What community Cancer Centers Need to Know.
1/1/2006
This article written by Mintz Levin Attorneys Marie C. Infante and Stephen R. Bentfield for the Legal Corner of Oncology Issues, January/February 2006, discusses prescription drug medications prescribed by oncologists for the treatment of cancer and its many side effects and whether coverage for these costs is under Medicare Part B or Part D and what determines which program should be billed for the drug.
Stephen is an associate in the firm's Washington office, practicing in the Health Section. Prior to joining Mintz Levin, Stephen was an attorney and law clerk at leading national and Washington, D.C. firms. He has substantial experience working on projects with attorneys in several practice areas in addition to health law, including labor and employment, bankruptcy, general litigation, and corporate law.
Marie is a member of the Health Section in the firm's Washington D.C. office. In addition to more than 16 years of health care law experience, she also has extensive provider operations experience as a professional nurse and a health care executive.
